Rapamycin alleviates brain edema after focal cerebral ischemia reperfusion in rats.
Brain edema is a major consequence of cerebral ischemia reperfusion. However, few effective therapeutic options are available for retarding the brain edema progression after cerebral ischemia. Recently, rapamycin has been shown to produce neuroprotective effects in rats after cerebral ischemia reperfusion. Whether rapamycin could alleviate this brain edema injury is still unclear. In this study, the rat stroke model was induced by a 1-h left transient middle cerebral artery occlusion using an intraluminal filament, followed by 48 h of reperfusion. The effects of rapamycin (250 μg/kg body weight, intraperitoneal; i.p.) on brain edema progression were evaluated. The results showed that rapamycin treatment significantly reduced the infarct volume, the water content of the brain tissue and the Evans blue extravasation through the blood-brain barrier (BBB). Rapamycin treatment could improve histological appearance of the brain tissue, increased the capillary lumen space and maintain the integrity of BBB. Rapamycin also inhibited matrix metalloproteinase 9 (MMP9) and aquaporin 4 (AQP4) expression. These data imply that rapamycin could improve brain edema progression after reperfusion injury through maintaining BBB integrity and inhibiting MMP9 and AQP4 expression. The data of this study provide a new possible approach for improving brain edema after cerebral ischemia reperfusion by administration of rapamycin.
Department of Neurology, Binzhou Medical College Affiliated Hospital , Binzhou, Shandong Province , China and.
Wei
W
Guo
Guoying
G
Feng
Yanying
Y
Miao
Guixiang
G
Liu
Chunsheng
C
Xu
D000818:Animals; D051401:Aquaporin 4 / Q000032:analysis / Q000235:genetics; D001812:Blood-Brain Barrier / Q000648:ultrastructure; D001921:Brain / Q000187:drug effects / Q000473:pathology; D001929:Brain Edema / Q000188:drug therapy*; D002545:Brain Ischemia / Q000150:complications*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000032:analysis / Q000235:genetics; D010539:Permeability; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000188:drug therapy*; D020123:Sirolimus / Q000627:therapeutic use*
C496032:Aqp4 protein, rat; D051401:Aquaporin 4; D020780:Matrix Metalloproteinase 9; C572337:Mmp9 protein, rat; D020123:Sirolimus
Aquaporin 4; brain; cerebral edema; cerebral ischemia reperfusion; matrix metalloproteinase 9; rapamycin